Anticipated Classes of New Medications and Molecular Targets for Pulmonary Arterial Hypertension-Reference-Cited by-同舟云学术

Anticipated Classes of New Medications and Molecular Targets for Pulmonary Arterial Hypertension

Published:2013-01 Issue:1 Volume:3 Page:226-244
ISSN:2045-8940
Container-title:Pulmonary Circulation
language:en
Short-container-title:Pulm. circ.

Author:

Morrell Nicholas W.¹,Archer Stephen L.²,DeFelice Albert³,Evans Steven⁴,Fiszman Monica⁵,Martin Thomas⁶,Saulnier Muriel⁵,Rabinovitch Marlene⁷,Schermuly Ralph⁷,Stewart Duncan⁸,Truebel Hubert⁹,Walker Gennyne¹⁰,Stenmark Kurt R.¹¹

Affiliation:

1. Department of MedicineUniversity of CambridgeUK

2. Department of MedicineUniversity of ChicagoChicagoIllinoisUSA

3. Food and Drug AdministrationChicagoIllinoisUSA

4. Pulmonary Vascular Diseases DivisionInflammation and Remodeling Research UnitPfizerCambridgeMassachusettsUSA

5. Food and Drug AdministrationSilver SpringMarylandUSA

6. CSURespiratory Development FranchiseNovartis Pharmaceuticals CorporationUK

7. Department of Internal MedicineJustus‐Liebig‐University GiessenUniversity of Giessen and Marburg Lung CenterOttawaCanada

8. Division of MedicineOttawa Hospital Research InstituteOttawaCanada

9. Vascular DiseasesBayer Pharma AGWuppertalGermany

10. Gilead Sciences Inc.CaliforniaUSA

11. Section of Critical Care PediatricsUniversity of ColoradoDenverColoradoUSA

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.4103/2045-8932.109940

Reference215 articles.

1. Emerging concepts and translational priorities in pulmonary arterial hypertension;Michelakis ED;Circulation,2008

2. Stress Doppler echocardiography in relatives of patients with idiopathic and familial pulmonary arterial hypertension: Results of a multicenter European analysis of pulmonary artery pressure response to exercise and hypoxia;Grunig E;Circulation,2009

3. Survival in pulmonary arterial hypertension: A reappraisal of the NIH risk stratification equation;Thenappan T;Eur Respir J,2010

4. Cellular and molecular pathobiology of pulmonary arterial hypertension;Humbert M;J Am Coll Cardiol,2004

5. Molecular pathogenesis of pulmonary arterial hypertension;Rabinovitch M;J Clin Invest,2008

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Parathyroid Hormone Related Protein (PTHrP)-Associated Molecular Signatures in Tissue Differentiation and Non-Tumoral Diseases;Biology;2023-07-03

2. Cross-talk between TSC2 and the extracellular matrix controls pulmonary vascular proliferation and pulmonary hypertension;Science Signaling;2022-12-06

3. New Insight in HDACs: Potential Therapeutic Targets for the Treatment of Atherosclerosis;Frontiers in Pharmacology;2022-04-21

4. Anticipated pharmacological role of Aviptadil on COVID-19;Environmental Science and Pollution Research;2021-11-30

5. TSC2-extracellular matrix crosstalk controls pulmonary vascular proliferation and pulmonary hypertension;2021-08-10